Bio21 foreshadows new collaborations
01 July, 2002 by Tanya HollisMelbourne's Bio21 precinct is starting to make new waves, with at least three potential collaborations currently on the boil.
Concern over US plan to push up patent fees
28 June, 2002 by Pete YoungA push for higher fees by the US Patent and Trademark Office (PTO) could spell trouble for small Australian biotechs and technology transfer companies.
Grant money comes through for research facilities
28 June, 2002 by Pete YoungAfter nine months of confusion and frustration, 15 major research facilities appear poised to enjoy the benefits of a five-year, $150 million Federal Government grant scheme.
IDT finalises trials facility purchase
27 June, 2002 by Tanya HollisMelbourne-based contract research and drug manufacturing company Institute of Drug Technology Australia (ASX: IDT) has finalised its purchase of a human clinical trials facility in Adelaide.
US bio-IT outfit Tripos sets up shop in Aust
27 June, 2002 by Pete YoungUS bioinformatics software and discovery research company Tripos has reacted to the expanding Australian life science sector by setting up a direct presence here for the first time.
Monash appoints new synchro chair
26 June, 2002 by Tanya HollisMonash University has appointed Australia's first Professor of X-ray and Synchrotron Physics to build a research base for the National Synchrotron Project.
Biotech hits a big six in CRC applications
26 June, 2002 by Pete YoungBiotechnology is making room for itself at the high table of Australia's scientific-industrial community, judging from the number of biotech-centric applications in the latest round of Cooperative Research Centre (CRC) funding.
Vic govt in big biotech hiring push
25 June, 2002 by Tanya HollisThe Victorian Government's Science, Technology and Innovation division has advertised five newly created roles as it works towards implementation of its Biotechnology Strategic Development Plan.
Adelaide uni plants its new vice-chancellor
25 June, 2002 by Melissa TrudingerUniversity of Adelaide's new vice-chancellor, Prof James McWha, is a plant biologist with plans to strengthen the university's already large contributions to research and development.
A Bob each way on biotech
24 June, 2002 by Tanya HollisFor sought-after biotech director Bob Moses, the industry has a lot of parallels with another of his passions - horse racing.
Kinacia CEO Murdoch joins Prana
24 June, 2002 by Tanya HollisKinacia's chief executive officer Dr Ross Murdoch has jumped ship to join Alzheimer's disease treatment developer Prana Biotechnology in a newly created role.
Study to look at ethics in biobusiness
21 June, 2002 by Iain ScottResearch at the University of Newcastle is investigating the role of ethics and ethics education in biotechnology.
Venture Capital: Bridging the gulf
20 June, 2002 by Iain ScottOf all the developments in Australian biotechnology in the last five years, one of the most accelerated has been the industry's burgeoning relationship with venture capital.
Peter Doherty: back into the fold
18 June, 2002 by Melissa TrudingerWhen Australian Nobel Laureate Peter Doherty won the 1996 Nobel Prize for Medicine, little did he know it would be his ticket back to Australia.
Comment invited on Trans-Tasman regulatory body proposal
18 June, 2002 by Melissa TrudingerA proposal to combine the Australian Therapeutic Goods Administration (TGA) and the New Zealand Medicines and Medical Devices Safety Authority Medsafe into a single agency accountable to both the Australian and New Zealand governments has been released as a discussion paper.
